Neutral
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q2 Loss, Lags Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?